Presumed cytomegalovirus retinitis in human immunodeficiency virus type I-infected South African children
O'connell, N.; Freeman, N.; Rabie, H.; Cotton, M.F.
Pediatric Infectious Disease Journal 30(6): 539-540
2011
ISSN/ISBN: 1532-0987 PMID: 21206397 DOI: 10.1097/inf.0b013e3182092ca0Document Number: 219680
In human immunodeficiency virus-infected children, cytomegalovirus causes retinitis alone, with dissemination, or with immune reconstitution inflammatory syndrome. We describe 6 severely immunosuppressed African children (median age, 6.7 months) with cytomegalovirus disease. Of the 6 children, 5 had clinical features suggesting ocular disease at presentation. The child in whom retinitis was detected through preemptive screening due to systemic disease achieved normal visual outcome.
Document emailed within 0-6 h
Related Documents
Obimbo, E.M.; Mbori-Ngacha, D.A.; Ochieng, J.O.; Richardson, B.A.; Otieno, P.A.; Bosire, R.; Farquhar, C.; Overbaugh, J.; John-Stewart, G.C. 2004: Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children Pediatric Infectious Disease Journal 23(6): 536-543Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Taha, T.E.; Graham, S.M.; Kumwenda, N.I.; Broadhead, R.L.; Hoover, D.R.; Markakis, D.; van Der Hoeven, L.; Liomba, G.N.; Chiphangwi, J.D.; Miotti, P.G. 2000: Morbidity among human immunodeficiency virus-1-infected and -uninfected African children Pediatrics 106(6): E77
Arpadi, S.M.; Markowitz, L.E.; Baughman, A.L.; Shah, K.; Adam, H.; Wiznia, A.; Lambert, G.; Dobroszycki, J.; Heath, J.L.; Bellini, W.J. 1996: Measles antibody in vaccinated human immunodeficiency virus type 1-infected children Pediatrics 97(5): 653-657
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Monteiro, J.P.; Freimanis-Hance, L.; Faria, L.B.; Mussi-Pinhata, M.M.; Korelitz, J.; Vannucchi, H.él.; Queiroz, W.; Succi, R.C.M.; Hazra, R. 2009: Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin e Nutrition Research 29(10): 716-722
Mosebi, S.; Morris, L.; Dirr, H.W.; Sayed, Y. 2008: Active-site mutations in the South african human immunodeficiency virus type 1 subtype C protease have a significant impact on clinical inhibitor binding: kinetic and thermodynamic study Journal of Virology 82(22): 11476-11479
Adler, D.; de Bruyn, G.; Laher, F.; Gray, G.; Allan, B.R.; Williamson, A.-L. 2008: Human papillomavirus genotype distribution among human immunodeficiency virus (HIV)-infected and non-HIV-infected women in Soweto, South Africa Journal of Clinical Microbiology 46(12): 4109-4110
Nyasulu, P.; Cohen, C.; De Gouveia, L.; Feldman, C.; Klugman, K.P.; von Gottberg, A.; Vasaikar, S.; Smith, P.; Janse van Rensburg, N.; Moller, A.; Sein, P-Pyu.; Hoosen, A.; Ahmed, K.; Lekalakala, R.; Perovic, O.; Karstaedt, A.; Kilner, D.; Crewe-Brown, H.; Wadula, J.; Dove, M.; Lindeque, K.; Weldhagen, G.; Meyer, L.; Sturm, W.; Vanmali, T.; Hamese, K.; Bauer, K.; Hoyland, G.; Mutanda, C.; Lebudi, J.; Simpson, J.; Roditi, D.; Whitelaw, A.; Liebowitz, L.; Hoffman, R.; Wasserman, E.; Brink, A.; Heney, C.; Senekal, M.; Schuchat, A.; Schrag, S.; Keddy, K.; Frea 2011: Increased risk of death in human immunodeficiency virus-infected children with pneumococcal meningitis in South Africa, 2003-2005 Pediatric infectious disease journal 30(12): 1075-1080
Palacios, G.C.; Montalvo, M.S.; Fraire, M.I.; Leon, E.; Alvarez, M.T.; Solorzano, F. 2008: Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy International Journal of Pediatric Otorhinolaryngology 72(11): 1671-1681
Saxinger, C.; Levine, P.H.; Dean, A.; Lange Wantzin, G.; Gallo, R. 1984: Unique pattern of human t cell leukemia virus type iii acquired immunodeficiency syndrome related antigen recognition by sera from african children in uganda 1972 Cancer Research 45(9 Suppl): 4624S-4626S
Farquhar, C.; Wamalwa, D.; Selig, S.; John-Stewart, G.; Mabuka, J.; Majiwa, M.; Sutton, W.; Haigwood, N.; Wariua, G.; Lohman-Payne, B. 2009: Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination Pediatric Infectious Disease Journal 28(4): 295-299
Lang, D.J.; Kovacs, A.A.; Zaia, J.A.; Doelkin, G.; Niland, J.C.; Aledort, L.; Azen, S.P.; Fletcher, M.A.; Gauderman, J.; Gjerset, G.J. 1989: Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group Journal of Acquired Immune Deficiency Syndromes 2(6): 540-549
Surachatkumtonekul, T.; Chokephaibulkit, K.; Vanprapar, N.; Pamonvaechavan, P. 2008: Treatment of cytomegalovirus (CMV) retinitis with intravitreous ganciclovir in HIV-infected children Journal of the Medical Association of Thailand 91(3): 331-337
Javier Nuño, F.; Noval, J.; Llorente, R.; Viejo, G. 2000: Hemophagocytic syndrome associated with cytomegalovirus and Mycobacterium xenopi disseminated disease in a patient infected by the human immunodeficiency virus who had a fatal outcome Enfermedades Infecciosas y Microbiologia Clinica 18(2): 96-97
Ryder, R.W.; Oxtoby, M.J.; Mvula, M.; Batter, V.; Baende, E.; Nsa, W.; Davachi, F.; Hassig, S.; Onorato, I.; Deforest, A. 1993: Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1 Journal of Pediatrics 122(5 Part 1): 697-702
Porras Luque, J.I.; Buezo, G.F.; Dauden Tello, E. 1997: Significado de la presencia y papel patogénico del citomegalovirus en patologia cutáneo-mucosa de pacientes con infección por el virus de la inmunodeficiencia humana - Meaning of the presence and pathogenetic role of cytomegalovirus in skin and mucosal disorders of patients infected with human immunodeficiency virus Actas Dermo-Sifiliograficas (Ed. Impresa) 88(11): 597-612
Gordon, M.; Deeks, S.; De Marzo, C.; Goodgame, J.; Guralnik, M.; Lang, W.; Mimura, T.; Pearce, D.; Kaneko, Y. 1997: Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity Journal of Medicine 28(1-2): 108-128
Arévalo Velasco, A.; Mateo Rodríguez, F.; Sánchez Pérez, M.A.; Alonso Claudio, G.; Pérez Arellano, J.L.; Fuertes Martín, A. 1997: Iron metabolism in patient infected by human immunodeficiency virus type 1 Sangre 42(5): 345-349
Rasheed, S.; Li, Z.; Xu, D.; Kovacs, A. 1996: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women American Journal of Obstetrics and Gynecology 175(1): 122-129